Graduated from Kazan State Medical University in the Republic of Tatarstan, Russia with a Doctorate of Medicine in 2007. In 2008, he completed a 1-year internship in Internal Medicine, and he was certified as a clinical pharmacologist in 2009. In 2012, he graduated from the Academy of National Economy and Public Administration with a bachelor’s degree in Public Administration. Since 2012, he has held a Ph.D. in Clinical Pharmacology.
From 2009 to 2016, he worked as an assessor/reviewer at the Ministry of Health, assessing clinical trial applications (INDs) and marketing authorization applications (NDAs, BLAs, ANDAs).
Beginning in 2016, he has been a regulatory affairs and drug development consultant.
From 2017 to 2019, he worked as a regulatory affairs consultant at the Korean Ministry of Health, supporting Korean manufacturers in penetrating Russian and Eurasian pharmaceutical markets.
He has over 40 publications in scientific journals. His areas of interest include regulatory affairs, biotechnology, gene and cell therapy, biosimilars, pharmaceutical development, early development, and pharmaceutical legislation in the US and EU.